{
  "id": 9539361,
  "title": "Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T",
  "url": "https://urgent.news/2026/09/24/kyverna-says-long-term-data-bolster-fda-submission-for-rare",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T10:02:50.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/kyverna-says-long-term-data-bolster-fda-submission-for-car-t-in-rare-autoimmune-disease/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Kyverna Therapeutics touted positive one-year results on Thursday in patients with a rare autoimmune disorder called stiff person syndrome. The condition affects about 6,000 patients in the US, causing painful muscle spasms and stiffness. Kyverna’s ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}